Filippos Kottakis
Principal Investigator, Biology at Covant Therapeutics
Based in Boston, United States
7-day free trial · no credit card
Seniority
Director
Department
Science
Location
Boston
Industry
Biotechnology Research
Company size
14
Contact information
Reveal Filippos's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
f•••••••@covanttx.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Filippos Kottakis
With an expansive background on immunology, immuno-oncology and cancer, my journey, starting from academia all the way to Covant Therapeutics has been marked by a deep commitment to pioneering novel treatments. My expertise in target identification and drug discovery has been instrumental in advancing research and development initiatives, consistently pushing the boundaries of what's possible in the fight against disease. At the core of my efforts lies a collaborative spirit and a relentless pursuit of innovation. I have embraced the complexities of drug discovery and I am dedicated to translating scientific insights into potent, life-changing therapies. My mission is to empower patients, and every day I am making strides towards turning this vision into reality.
Decision-makers
Other people at Covant Therapeutics
- MCDirector
Matthew Cullen
Director · General Business & Management
- JAOther
Jagat Adhikari
Associate Director Translational Proteomics · Other
- JROther
Jamie Rice
Head of Discovery Biology · Other
- HLOther
Huay-Keng Loke
Senior Director of Biochemistry and Structural Sciences · Other
- CDOther
Christopher Dawson
Senior Investigator, Structural Biology · Other
Build a list of verified contacts at Covant Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Filippos
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime